Tango Therapeutics Inc (TNGX)
7.61
+0.02
(+0.26%)
USD |
NASDAQ |
May 03, 16:00
7.615
0.00 (0.00%)
After-Hours: 20:00
Tango Therapeutics Revenue (TTM): 36.53M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 36.53M |
| September 30, 2023 | 37.51M |
| June 30, 2023 | 33.70M |
| March 31, 2023 | 24.87M |
| December 31, 2022 | 24.86M |
| September 30, 2022 | 24.16M |
| Date | Value |
|---|---|
| June 30, 2022 | 24.03M |
| March 31, 2022 | 36.41M |
| December 31, 2021 | 37.04M |
| September 30, 2021 | 40.47M |
| June 30, 2021 | 22.42M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
22.42M
Minimum
Jun 2021
40.47M
Maximum
Sep 2021
31.09M
Average
33.70M
Median
Jun 2023
Revenue (TTM) Benchmarks
| Aquestive Therapeutics Inc | 50.58M |
| 2seventy bio Inc | 100.39M |
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 7.098M |
| iBio Inc | -- |